Confidentiality 4 Sample Clauses

Confidentiality 4. DŮVĚRNOST INFORMACÍ The Protocol, Study Drug, CRFs, and any and all information, data, reports or documents marked as „confidential“ disclosed to or generated by the Site or any Study Team members regarding the work performed under this Agreement (other than subject medical records) or which otherwise relates to this Study (“Confidential Information”) belong to Sponsor and shall not be disclosed by the Site to any third party or be used for any purpose other than the performance of the Study without the prior written consent of Sponsor, during the conduct of the Study and for a period of seven (7) years after the termination of the performance of the Agreement. The above obligations of confidentiality shall not apply to the extent Confidential Information: Protokol, léčiva použitá v rámci studie, případové formuláře (Case Report Formsxxxx xxx „CRF“) a veškeré informace, údaje, zprávy nebo dokumenty označené jako „důvěrné“, které obdrží nebo vytvoří řešitelské centrum nebo člen studijního týmu na základě prací vykonávaných v souladu s touto Smlouvou nebo jinak souvisejících se studií (xxxx xxx „xxxxxxx informace“), jsou vlastnictvím Zadavatele a není oprávněno Řešitelskému centru sdělovat jakékoli třetí osobě ani používat k jakémukoli jinému účelu než při plnění studie bez předchozího písemného souhlasu Zadavatele během provádění studie a po dobu sedmi (7) let po ukončení Smlouvy. Výše uvedený závazek důvěrnosti informací se nevztahuje xx xxxxxxx informace v rozsahu, v jakém: (a) is or becomes, through no fault of the Site, part of the public knowledge; (a) jsou a nebo budou zveřejněny bez zavinění ze strany řešitelského centra; (b) the Site can demonstrate was already lawfully in the Site’s possession on the date of disclosure to the Site and not (b) může Řešitelské centrum prokázat, že k datu jejich sdělení řešitelskému centru již byly legálně řešitelskému centru známy, subject to prior confidentiality obligations; aniž by podléhaly předchozímu závazku důvěrnosti informací; (c) is acquired by the Site from any third party without restrictions on disclosure; or (c) Řešitelské centrum získalo od nějaké třetí osoby bez omezení týkajících se jejich sdělování; (d) is developed by the Site independently, without the use or benefit of Confidential Information, and as evidenced. (d) Řešitelské centrum vytvořilo nezávisle na obdržení důvěrných informací podle této Smlouvy, což lze prokázat.
AutoNDA by SimpleDocs
Confidentiality 4. 1 The Supplier acknowledges and confirms that all information provided to it by the Province hereunder, or to which the Supplier has access as a result of providing the Services to the Province is confidential information (“Confidential Information”). Unless required by law or an order of a court of competent jurisdiction, such Confidential Information shall not, either during the Initial Term or Renewal Term or at any time thereafter, be disclosed by the Supplier, without the prior written consent of the Province, to any third party or to any employees of the Supplier, other than its employees who are directly involved in providing the Services.
Confidentiality 4. The parties agree not to divulge to any third party any confidential, non-public and/or proprietary information belonging to the other party, including the terms of this Agreement, unless (a) the confidential information is in or enters the public domain other than by a breach of the receiving party; or (b) the receiving party obtains the confidential information lawfully from a third party who is authorized to disclose the confidential information; or (c) the receiving party is required to disclose the confidential information by law, regulation or an order of a court of competent jurisdiction.
Confidentiality 4 

Related to Confidentiality 4

  • Confidentiality Statement All persons that will be working with PHI COUNTY 21 discloses to CONTRACTOR or CONTRACTOR creates, receives, maintains, or transmits on behalf of 22 COUNTY must sign a confidentiality statement that includes, at a minimum, General Use, Security and 23 Privacy Safeguards, Unacceptable Use, and Enforcement Policies. The statement must be signed by the 24 workforce member prior to access to such PHI. The statement must be renewed annually. The 25 CONTRACTOR shall retain each person’s written confidentiality statement for COUNTY inspection 26 for a period of six (6) years following the termination of the Agreement.

  • Confidentiality Provisions 7.1 Pursuant to 42 USC 1396r-8(b)(3)(D), the parties agree that information disclosed by the Manufacturer under this Agreement in a form which discloses the identity of a specific Manufacturer or the prices charged for drugs by the Manufacturer is confidential and shall not be disclosed except as necessary to carry out the Agreement or as may be required by judicial order. Therefore, the Department agrees that confidential information provided to the Department under this Agreement, including the Agreement itself is exempted from disclosure by statute. To the extent that the Department utilizes the services of a third-party to develop and maintain the PDL or to administer any part of this Agreement, all provisions of this section shall apply to the third- party, and the Department shall have the third-party sign a written agreement ensuring the third- party will comply with all aspects of this section. In the event that the Department is required by law to disclose any provision of this Agreement or pricing information to any person other than as provided above, the Department shall provide advance written notice to the Manufacturer sufficiently in advance of the proposed disclosure to allow the Manufacturer to seek a protective order or other relief. 7.2 The parties agree that information revealing the identity of Medicaid recipients is confidential and shall not be disclosed except as necessary to carry out this Agreement or as may be required by judicial order. The foregoing shall not prevent the disclosure by the Manufacturer to the Department of information regarding the National Rebates for Covered Products. 7.3 The Manufacturer will hold the Utilization Information confidential. If the Manufacturer audits this information or receives further information on such data, that information shall also be held confidential. The Manufacturer shall have the right to disclose Utilization Information to auditors who agree to keep such information confidential. 7.4 The provisions of this section and any confidentiality agreement executed pursuant to this section shall survive termination or expiration of this Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!